Overexpression of Polo-Like Kinase 1 Is a Common and Early Event in Pancreatic Cancer

Publisher： Karger

E-ISSN： 1424-3911|5|2-3|259-265

ISSN： 1424-3903

Source： Pancreatology, Vol.5, Iss.2-3, 2005-05, pp. : 259-265

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Overexpression of Polo-Like Kinase 1 (PLK1) and Chromosomal Instability in Bladder Cancer

By  

Oncology, Vol. 70, Iss. 3, 2006-07 ,pp. : 231-237

Karger

Access to resources Recommend Favorite

Silencing of Polo-Like Kinase (Plk) 1 via siRNA Causes Inhibition of Growth and Induction of Apoptosis in Human Esophageal Cancer Cells

By  

Oncology, Vol. 74, Iss. 3-4, 2008-08 ,pp. : 198-206

Karger

Access to resources Recommend Favorite

Comprehensive Biomarker Analyses in Patients with Advanced or Metastatic Non-Small Cell Lung Cancer Prospectively Treated with the Polo-Like Kinase 1 Inhibitor BI2536

By  

Oncology Research and Treatment, Vol. 40, Iss. 7-8, 2017-06 ,pp. : 435-439

Karger

Access to resources Recommend Favorite

Expression of Polo-Like Kinase 1 (PLK1) Protein Predicts the Survival of Patients with Gastric Carcinoma

By  

Oncology, Vol. 70, Iss. 2, 2006-05 ,pp. : 126-133

Karger

Access to resources Recommend Favorite

Polo-Like Kinase 1 as a New Target for Non-Hodgkin’s Lymphoma Treatment

By  

Oncology, Vol. 74, Iss. 1-2, 2008-06 ,pp. : 96-103

Karger

Access to resources Recommend Favorite